Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Nanotechnology-Based Strategy for Enhancing Therapeutic Efficacy in Pancreatic Cancer: Receptor-Targeted Drug Delivery by Somatostatin Analog

International Journal of Molecular Sciences(2024)10.3390/ijms25105545Source: DataRank Database

Nanotechnology-Based Strategy for Enhancing Therapeutic Efficacy in Pancreatic Cancer: Receptor-Targeted Drug Delivery by Somatostatin Analog is a research paper published in International Journal of Molecular Sciences (2024). On theSindex it has a DataRank of 0. It has been cited 9 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access9 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (2 grants)OA: goldTopics (38)IDs (PubMed, PMC)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (7)

Joydeb Majumder ORCID,Olena Taratula ORCID,Andriy Kuzmov,Olga B. Garbuzenko ORCID,Natalia Pogrebnyak

Live enrichment

PubMed:38791582 PMC:PMC11122428

NIH/NCI

Grant: R01 CA209818

National Institutes of Health

Grant: 5R01CA209818-03

Tumor-targeted nanoparticle-based delivery system for imaging and treatment of cancer

goldLicense: cc-by

publisherhttps://www.mdpi.com/1422-0067/25/10/5545/pdf?version=1716112190

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC11122428/pdf/ijms-25-05545.pdf

Unpaywallhttps://doi.org/10.3390/ijms25105545

Europe_PMChttps://europepmc.org/articles/PMC11122428

Europe_PMChttps://europepmc.org/articles/PMC11122428?pdf=render

Fields of Study

0301 basic medicine0303 health sciences03 medical and health sciences

MeSH Terms

Cell Line, TumorAnimalsHumansMiceCarcinoma, Pancreatic DuctalPancreatic NeoplasmsPaclitaxelOctreotideSomatostatinReceptors, SomatostatinAntineoplastic AgentsLiposomesDrug Delivery SystemsXenograft Model Antitumor AssaysNanotechnology

Keywords

LiposomePaclitaxelSomatostatin Receptor 2 (Sstr2)Targeted Delivery SystemNanoparticle-based DrugsAntineoplastic AgentsOctreotideXenograft Model Antitumor AssaysArticlePancreatic NeoplasmsMiceDrug Delivery SystemsCell Line, TumorLiposomesAnimalsHumansNanotechnologyReceptors, SomatostatinSomatostatinCarcinoma, Pancreatic Ductal

Sustainable Development Goals

SDG 3: 3. Good health